...BRCA1 or 2), but most of the time it remains unknown. However, all women considered at high risk, because of their famil...
...BRCA1/BRCA2.,We sequenced BRCA1/BRCA2 in 1,469 population-based female breast cancer patients diagnosed between the ages...
...BRCA1, in 43% of samples for the tissue inhibitor of metalloproteinase 3 gene TIMP-3, in 38% of samples for the cyclin-d...
We investigated the uptake of genetic testing by 54 families in South East Scotland with a BRCA1/2 mutation. At a median...
...BRCA1 missense variant M1775K is pathogenic. Functional assays in yeast and mammalian cells showed that the BRCA1 BRCT d...
The objective of the present study was to investigate the mutational spectrum of BRCA1 and BRCA2 in the Valencian Commun...
...BRCA1/BRCA2 hereditary breast cancer patients. A total of 494 coding exons were screened by denatured high-performance l...
...BRCA1/2-negative families and is similar to the frequency of BRCA1 hypermethylation in inherited and sporadic breast and...
...BRCA1/2 genetic testing with their children, especially adolescent children. What is less known is the extent to which t...
...BRCA1/2 mutation status. A complete analysis of the BRCA1/2 coding regions was performed on the 217 women from high-risk...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
